Morgan Stanley Downgrades Staar Surgical to Underweight, Lowers Price Target to $37
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley has downgraded Staar Surgical (NASDAQ:STAA) from Equal-Weight to Underweight and lowered the price target from $50 to $37.
July 15, 2024 | 10:09 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Morgan Stanley analyst Patrick Wood has downgraded Staar Surgical from Equal-Weight to Underweight and reduced the price target from $50 to $37.
The downgrade from a major financial institution like Morgan Stanley and the significant reduction in the price target are likely to negatively impact investor sentiment and the stock price of Staar Surgical in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100